Plancorp, LLC Editas Medicine, Inc. Transaction History

Plancorp, LLC

  • $2.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$39.71 - $90.58 $149,508 - $341,033
-3,765 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$27.07 - $84.35 $101,918 - $317,577
3,765 New
3,765 $264,000
Q1 2018

Apr 16, 2018
SELL
$29.84 - $44.08 $228,246 - $337,167
-7,649 Closed
0 $0
Q4 2017

Jan 19, 2018
BUY
$21.89 - $31.34 $167,436 - $239,719
7,649
7,649 $235,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email